Hormone Therapy Risk in Postmenopausal ER+ Breast Cancer Hormone Therapy Risk in Postmenopausal ER+ Breast Cancer
Hormone therapy did not increase mortality in postmenopausal women treated for early-stage estrogen receptor –positive breast cancer, but there was a recurrence risk with vaginal estrogen therapy.MDedge News
Source: Medscape ObGyn and Womens Health Headlines - Category: OBGYN Tags: Hematology-Oncology News Source Type: news
More News: Breast Cancer | Cancer | Cancer & Oncology | Hematology | Hormonal Therapy | Hormones | OBGYN | Women